Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElementis Regulatory News (ELM)

Share Price Information for Elementis (ELM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 141.00
Bid: 140.60
Ask: 141.60
Change: 0.40 (0.28%)
Spread: 1.00 (0.711%)
Open: 144.00
High: 144.00
Low: 138.00
Prev. Close: 140.60
ELM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

28 Oct 2011 07:00

RNS Number : 0073R
Elementis PLC
28 October 2011
 



 

28 October 2011

 

 

Elementis - Interim Management Statement

 

Elementis plc (the "Company") today issues its Interim Management Statement for the period since 1 July 2011 in relation to the Company and its subsidiaries (the "Group").

 

Commenting on the Company's performance Group Chief Executive, David Dutro, said: "Trading for the third quarter of this year is ahead of the same period in 2010, with all three Group businesses showing improved earnings. Specialty Products has a greater geographic breadth, a more impressive new product pipeline and a stronger team than in prior years, and the new Chromium model is proving to be more resilient than in the past. Consequently, we remain confident that full year earnings, before exceptional items*, will be in line with our expectations."

 

In Specialty Products, sales in the third quarter were 12 per cent ahead of the same period last year as the business continued to benefit from strong demand in a number of sectors plus newly introduced product sales and market share gains.

 

·; Sales of coatings additives improved by 11 per cent in North America as Elementis continued to gain share in that region. In Europe, sales increased by 12 per cent helped by positive currency movements which offset some softness in Southern Europe. In Asia Pacific, the business has been engaged in an ongoing programme of portfolio optimisation which has impacted sales, but improved margins, compared to the same period last year. In addition, Chinese Government initiatives to reduce inflation and conserve energy have had a temporary impact on coatings demand. As a consequence, third quarter sales in Asia Pacific were 4 per cent lower than the previous year.

 

·; Sales to the oilfield drilling sector have continued to grow rapidly and will be supported going forward by the expansion of our Charleston facility. Sales in the third quarter were 48 per cent ahead of last year. Demand for high quality additives and technical service in shale gas and oil drilling has continued to be robust and there has also been solid demand from more traditional North American drilling activity.

 

·; In Personal Care, sales in our core European market grew by 5 per cent, excluding currency, and the business continues to make inroads in North America and Asia Pacific.

 

Third quarter operating margins in Specialty Products were above 20 per cent, which is consistent with the first half of the year and ahead of the same period last year, as the business has continued to benefit from pricing discipline and a progression towards a higher value product portfolio.

 

In Chromium, sales increased by 8 per cent compared to the third quarter of 2010 with all production facilities continuing to run at high operating rates. Global demand for Chromium chemicals has continued to be robust, allowing the business to steadily increase the proportion of its sales going into the core North American market, which represented 63 per cent of Chromium sales in the quarter compared to 56 per cent in the first 6 months of 2011. This positive change in mix combined with the ongoing benefits being realised from the change to natural gas at the Castle Hayne facility, announced earlier this year, has meant that operating margins have continued to improve, exceeding those reported for the first six months of the year.

 

Group cash flow continued to be strong and it is likely that the balance sheet will show a net cash position at the end of the year.

 

* Exceptional items consist mainly of the Euro 23.4 million that was refunded with interest on 1 August 2011, following the successful EU Commission appeal

 

- END -

 

Enquiries:

 

Elementis plc

020 7408 9300

Brian Taylorson, Finance Director

Financial Dynamics

020 7831 3113

Deborah Scott

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSUBSNRAWARUAA
Date   Source Headline
30th May 202412:52 pmRNSDirector/PDMR Shareholding
29th May 20241:07 pmRNSDirector Declaration
8th May 202411:08 amRNSDirector/PDMR Shareholding
3rd May 202411:46 amRNSHolding(s) in Company
1st May 202410:06 amRNSTotal Voting Rights
30th Apr 202411:36 amRNSResult of AGM
30th Apr 20247:00 amRNSFirst quarter trading update
29th Apr 202412:13 pmRNSResponse to open letter from Gatemore
12th Apr 202411:33 amRNSDirector/PDMR Shareholding
12th Apr 202411:28 amRNSDirector/PDMR Shareholding
9th Apr 20246:04 pmRNSDirector/PDMR Shareholding
26th Mar 20244:07 pmRNSAnnual Financial Report & Notice of AGM
19th Mar 20243:02 pmRNSAdditional Listing
15th Mar 20241:00 pmRNSDirectorate Change
12th Mar 20244:38 pmRNSDirector/PDMR Shareholding
12th Mar 20244:33 pmRNSDirector/PDMR Shareholding
8th Mar 20245:56 pmRNSDirector/PDMR Shareholding
7th Mar 20247:00 amRNSDirectorate changes
7th Mar 20247:00 amRNSPreliminary results year ended 31 December 2023
1st Mar 20249:30 amRNSBlock listing Interim Review
18th Jan 20247:00 amRNSTrading Update
2nd Jan 20249:45 amRNSTotal Voting Rights
1st Dec 202310:46 amRNSTotal Voting Rights
30th Nov 20239:38 amRNSDirector/PDMR Shareholding
14th Nov 20237:00 amRNS2023 Capital Markets Day
1st Nov 20239:46 amRNSTotal Voting Rights
31st Oct 20237:00 amRNSThird Quarter Trading Update
2nd Oct 20239:34 amRNSTotal Voting Rights
20th Sep 202312:09 pmRNSResponse to open letter from Franklin Templeton
12th Sep 20233:13 pmRNSDirector Declaration
8th Sep 20239:30 amRNSHolding(s) in Company
1st Sep 20239:49 amRNSBlock listing Interim Review
1st Sep 20239:42 amRNSTotal Voting Rights
1st Aug 20239:44 amRNSTotal Voting Rights
27th Jul 20232:16 pmRNSHolding(s) in Company
27th Jul 20237:00 amRNSHalf-year Report
20th Jul 202312:58 pmRNSHolding(s) in Company
3rd Jul 202310:21 amRNSTotal Voting Rights
29th Jun 20234:29 pmRNSDirector/PDMR Shareholding
23rd Jun 20239:32 amRNSDirector/PDMR Shareholding
30th May 20238:06 amRNSDirector Declaration
2nd May 20239:37 amRNSTotal Voting Rights
26th Apr 20232:12 pmRNSResult of AGM
26th Apr 20237:00 amRNSAGM Trading Statement
17th Apr 202310:15 amRNSDirector/PDMR Shareholding
17th Apr 202310:10 amRNSDirector/PDMR Shareholding
13th Apr 20234:24 pmRNSDirector/PDMR Shareholding
3rd Apr 202311:28 amRNSDirector Declaration
3rd Apr 20239:34 amRNSTotal Voting Rights
24th Mar 20239:27 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.